Pharmacokinetic Evaluation of Risperidone and Its Active Metabolite When Risperidone Oral Solution Is Mixed with Black Tea in Rats
Pharmaceuticals · 29.05.2026 · 19 (6) · 855
DOI: 10.3390/ph19060855 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 29.05.2026. Verfasst von Yosuke Nishikawa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacy Practice Center, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sen…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Risperidone oral solution (RIS-OS) is an easy-to-administer treatment for schizophrenia designed to improve medication adherence and rapid onset of effect. Mixing RIS-OS with beverages such as black tea is prohibited due to reduced RIS concentrations observed in vitro, despite the absence of pharmacokinetic data. In this study, we evaluated the pharmacokinetics of RIS and its active metabolite 9-OH-RIS in rats following oral administration with black tea.
Methods
Male Wistar rats received RIS-OS intravenously or orally as a water or Dimbula black tea mixture; serial tail-vein blood samples were collected as dried blood spots, RIS and 9-OH-RIS were quantified using HPLC/ESI-MS/MS, and pharmacokinetic parameters were calculated and compared using Welch’s t-test.
Results
Compared with the water mixture, the black tea mixture significantly reduced RIS Cmax, while Tmax and AUC remained unchanged. Furthermore, AUMC and MRT were significantly higher. The results were similar for 9-OH-RIS. Despite reduced RIS content in vitro, no difference in absolute bioavailability was observed in vivo. Although only one black tea variety was tested, evaluating additional varieties may help identify the components responsible for reducing RIS content.
Conclusions
Mixing RIS-OS with black tea may delay absorption without reducing overall exposure, providing evidence that may contribute to safer guidance regarding beverage coadministration.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Pharmacy Practice Center, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai 981-8558, Japan.
- Department of Pharmacy, Tohoku Medical and Pharmaceutical University Hospital, 1-12-1 Fukumuro, Miyagino-ku, Sendai 983-8512, Japan.
- Division of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai 981-8558, Japan.
- Division of Clinical Pharmaceutics and Pharmacy Practice, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 1-12-1 Fukumuro, Miyagino-ku, Sendai 983-8512, Japan.
- Division of Clinical Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai 981-8558, Japan.
- Division of Community Medicine and Pharmacy, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai 981-8558, Japan.
ORCID-Profile: Yosuke Nishikawa, Hiroyuki Suzuki, Ryusuke Ouchi, Kensuke Usui, Takashi Watanabe, Kouji Okada, Yuriko Murai
Zitieren
APA
Nishikawa, Y., Suzuki, H., Ouchi, R., Konno, T., Usui, K., Watanabe, T., Okada, K., Kisara, S., & Murai, Y. (2026). Pharmacokinetic Evaluation of Risperidone and Its Active Metabolite When Risperidone Oral Solution Is Mixed with Black Tea in Rats. Pharmaceuticals, 19(6), 855. https://doi.org/10.3390/ph19060855
Vancouver
Nishikawa Y, Suzuki H, Ouchi R, Konno T, Usui K, Watanabe T, et al. Pharmacokinetic Evaluation of Risperidone and Its Active Metabolite When Risperidone Oral Solution Is Mixed with Black Tea in Rats. Pharmaceuticals. 2026;19(6):855. doi:10.3390/ph19060855
BibTeX
@article{Nishikawa2026,
author = {Nishikawa, Yosuke and Suzuki, Hiroyuki and Ouchi, Ryusuke and Konno, Taisuke and Usui, Kensuke and Watanabe, Takashi and Okada, Kouji and Kisara, Shigeki and Murai, Yuriko},
title = {Pharmacokinetic Evaluation of Risperidone and Its Active Metabolite When Risperidone Oral Solution Is Mixed with Black Tea in Rats},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {6},
pages = {855},
doi = {10.3390/ph19060855}
}
EUVIMED